Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 4;8(3):246-254.
doi: 10.4103/apjon.apjon_61_20. eCollection 2021 May-Jun.

Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial

Affiliations

Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial

Ting Mao et al. Asia Pac J Oncol Nurs. .

Abstract

Objective: The objective was to evaluate the effects of transcutaneous acupoint electric stimulation (TAES) and gastric electrical stimulation (GES) on cancer patients with chemotherapy-induced gastrointestinal (GI) symptoms.

Methods: A total of 122 lung cancer patients receiving chemotherapy were assigned randomly to the following two groups: control group (usual care group, n = 61) and intervention group (TAES plus GES, n = 61). TAES involved two acupoints such as Neiguan (PC6) and Zusanli (ST36). GES was performed at gastric pacing sites on the body surface such as the places of projection of gastric antrum and corpus on the body surface. GES was performed on these sites for 14 days continuously (25 min every time, once daily). The effects of TAES and GES on GI symptoms were assessed using the Memorial Symptom Assessment Scale on the day prior to chemotherapy (time point 1) and days 14 (time point 2) and 28 (time point 3) after chemotherapy.

Results: No significant differences in the demographic and disease-related variables were detected between the two groups. Differences in symptom occurrence and severity at time point 1 were not statistically significant between the two groups (both P > 0.05). At time points 2 and 3, GI symptoms such as loss of appetite, nausea, vomiting, diarrhea, and constipation in the stimulation group had statistically significantly improved compared with the control group (all P < 0.05).

Conclusions: TAES and GES were efficacious in relieving GI discomfort in lung cancer patients after chemotherapy. TAES combined with GES is a safe and easy-to-use tool to manage GI symptoms in practice.

Keywords: Chemotherapy; gastric electrical stimulation; gastrointestinal symptoms; lung cancer patients; transcutaneous acupoint electrical stimulation.

PubMed Disclaimer

Conflict of interest statement

The corresponding author, Prof. Yongyi Chen, is the editorial board member of the journal.

Figures

Figure 1
Figure 1
Neiguan location
Figure 2
Figure 2
Zusanli location
Figure 3
Figure 3
Gastric pacing position
Figure 4
Figure 4
Flowchart of the study

Similar articles

Cited by

References

    1. McIntyre A, Ganti AK. Lung cancer-A global perspective. J Surg Oncol. 2017;115:550–4. - PubMed
    1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50. - PubMed
    1. Huang Z, Qin Z, Yao Q, Wang Y, Liu Z. Moxibustion for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Evid Based Complement Alternat Med. 2017;2017:1–11. - PMC - PubMed
    1. van Lancker A, Velghe A, van Hecke A, Verbrugghe M, van Den Noortgate N, Grypdonck M, et al. Prevalence of symptoms in older cancer patients receiving palliative care: A systematic review and meta-analysis. J Pain Symptom Manage. 2014;47:90–104. - PubMed
    1. Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer. 2009;17:83–90. - PubMed

LinkOut - more resources